Skip to content

Genesis II Total Knee System

by Smith & Nephew, Inc. 510(k)

Active United States

510(k) K030612

Overview

The Genesis II Total Knee System is a cemented primary and revision knee arthroplasty device designed for total knee replacement. It features a femoral component with a deeper and more lateralized trochlear groove, along with an externally rotated design to improve alignment and stability during implantation.

This system is intended for use in orthopedic surgery settings and is supplied as a sterile, single-use device. It is approved under FDA 510(k) clearance (K030612) as substantially equivalent to predicate devices, with components including femoral, tibial, and patellar implants. Storage and handling must comply with manufacturer instructions to maintain sterility and functionality.

AI-generated from registry data, 19 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Abbreviated NumberK030612 Date27 May 2003ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
MBH
Device Class
Class II
Regulation
21 CFR Part 888.3565
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Other devices from Smith & Nephew, Inc.

See all devices from Smith & Nephew, Inc. →

Questions

  • What types of knee surgeries is the Genesis II Total Knee System designed for, and how does its design improve outcomes?

    The Genesis II Total Knee System is designed for both primary and revision total knee arthroplasty procedures. Its femoral component features a deeper, more lateralized trochlear groove and an externally rotated design, which helps improve alignment and stability during implantation. These design elements are intended to enhance the fit and function of the knee joint, potentially leading to better long-term outcomes for patients.

  • Is the Genesis II Total Knee System meant for reuse, or is it a single-use device, and how should it be stored?

    The Genesis II Total Knee System is supplied as a sterile, single-use device. To maintain sterility and functionality, storage and handling must strictly follow the manufacturer’s instructions provided by Smith & Nephew, Inc. This ensures the device remains uncontaminated and ready for use in a single surgical procedure.

  • What components are included in the Genesis II Total Knee System, and how are they intended to work together?

    The Genesis II Total Knee System includes three primary components: femoral, tibial, and patellar implants. These components are designed to work together during total knee replacement surgery, with the femoral component fitting over the thigh bone, the tibial component attaching to the shin bone, and the patellar component covering the kneecap. The system’s design aims to restore joint function and stability through precise alignment and compatibility of these parts.

  • How is the regulatory status of the Genesis II Total Knee System determined, and what does that mean for its use in clinical settings?

    The Genesis II Total Knee System holds FDA 510(k) clearance (K030612), which means it has been determined to be substantially equivalent to predicate devices already on the market. This clearance indicates that the device meets FDA standards for safety and effectiveness for its intended use in orthopedic surgery settings, allowing clinicians to rely on its regulatory approval when incorporating it into surgical procedures.